e-learning
resources
London 2016
Sunday, 04.09.2016
IPF: from pathogenesis to treatment I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of nintedanib on cough and health related quality of life in patients with idiopathic pulmonary fibrosis
M.J.G. van Manen (Rotterdam, Netherlands), Mirjam van Manen, Nelleke Tak, Henk Hoogsteden, Marlies Wijsenbeek
Source:
International Congress 2016 – IPF: from pathogenesis to treatment I
Session:
IPF: from pathogenesis to treatment I
Session type:
Thematic Poster
Number:
785
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M.J.G. van Manen (Rotterdam, Netherlands), Mirjam van Manen, Nelleke Tak, Henk Hoogsteden, Marlies Wijsenbeek. Effect of nintedanib on cough and health related quality of life in patients with idiopathic pulmonary fibrosis. Eur Respir J 2016; 48: Suppl. 60, 785
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Related content which might interest you:
Health-related quality of life in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Health-related quality of life and health status among patients with sarcoidosis, chronic obstructive pulmonary disease and interstitial lung disease
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018
Quality of life measures in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
The physical and psychological needs of patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)
Source: Eur Respir J 2010; 35: 118-123
Year: 2010
Quality of life of idiopathic pulmonary fibrosis patients
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017
Quality of life in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 30s
Year: 2005
Sleep quality among patients with idiopathic pulmonary fibrosis
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Impact on patients' health status following early identification of a COPD exacerbation
Source: Eur Respir J 2007; 30: 907-913
Year: 2007
Prognosis symptoms, quality of life and comorbidity relationship with cough in patients with idiopathic pulmonary fibrosis
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry
Source: International Congress 2016 – IPF clinical
Year: 2016
Quality of life of patients with idiopathic pulmonary fibrosis (IPF) - What can the Australian IPF registry tell us?
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
Detection of quality of life with COPD assessment test in chronic obstructive pulmonary disease and effect of dyspnea on disease-specific quality of life in these patients
Source: Annual Congress 2012 - Methodology in epidemiologic research
Year: 2012
Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
Source: Breathe, 15 (2) 144; 10.1183/20734735.0016-2019
Year: 2019
The burden of idiopathic pulmonary fibrosis reported by patients and carers in Ireland
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Health-related quality of life in COPD patients with chronic respiratory failure
Source: Eur Respir J 2008; 32: 379-386
Year: 2008
Predictors of health-related quality of life in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 66s
Year: 2006
Comparison of changes of the King’s brief interstitial lung disease questionnaire (K-BILD) with other health status measures
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
A longitudinal study of anxiety and depression in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Dyspnoa and health-related quality of life in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 570s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept